Obstetric and paediatric HIV surveillance data from the UK and Ireland
HIV prevalence among pregnant women England and Scotland only, 1997-2012 (PHE, HPS and ICH data)
21,226 pregnancies, diagnosed women since 1990, and reported 21,226 pregnancies, diagnosed women since 1990, and reported* by April 2016
Antenatal screening for HIV and impact
Timing of maternal HIV diagnosis UK & Ireland 1998-2015
Timing of maternal HIV diagnosis UK 1998-2015
Timing of diagnosis & ART at conception UK & Ireland 1998-2015
Sequential pregnancies by conception year, 1998-2014 Pregnancies reported by end April 2016, UK and Ireland
Changing mode of delivery among all diagnosed women Deliveries 2000-2015 reported by end April 2016*, UK births only
Uptake of antiretroviral therapy and MTCT rate by year of birth for 3703 infants born to diagnosed women 1990-2004
MTCT rates in diagnosed women, UK & Ireland 2000-2011
MTCT rates in diagnosed women, UK & Ireland 2000-2011
Infection status of children
Infection status of children born to women diagnosed with HIV before delivery: UK & Ireland Births reported to NSHPC by April 2016
Infection status of children born since 2000 to women diagnosed with HIV before delivery: UK Births reported to NSHPC by April 2016
Infection status of children born since 2000 to women diagnosed with HIV before delivery: Ireland Births reported to NSHPC by April 2016
ART & premature delivery Diagnosed HIV positive women in UK & Ireland, 1990-2005
ART & congenital abnormalities: 1990-2007 data
NSHPC data on congenital abnormalities provided to Antiretroviral Pregnancy Registry (APR)
HIV infection and exposure in children in the UK and Ireland
NSHPC paediatric follow-up protocol
Collaborative HIV Paediatric Study Started in 2000, a collaboration between NSHPC, MRC Clinical Trials Unit and centres looking after infected children
Follow up of uninfected children exposed to ART: CHART study 2002-05
First audit of perinatal HIV transmissions 2002-05
Perinatal HIV audit – UK births since 2006
The role of NSHPC: public health surveillance & epidemiological and clinical research / audit
Ethics MREC/04/2/009